Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
Explore this paper's citation graph
Summary
In a small number of patients, infusions of unirradiated donor leukocytes were an effective treatment for EBV-associated lymphoproliferative disease that arose after allogeneic bone marrow transplantation.
- Type
- article
- Published
- 1994-04-28
- Cited by
- 1,100
- References
- 35
- Access
- Open access
- OpenAlex
- https://openalex.org/W1977635228
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:45754968
Keywords
Medicine, Lymphoma, Lymphoproliferative disorders, Bone marrow, Epstein–Barr virus
References
- Epstein-Barr virus lymphoproliferation after bone marrow transplantation.
- Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
- Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.
- Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
- Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.
- Molecular genetic analysis of lymphoid tumors arising after organ transplantation.
- Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.
- Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.
- Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.
- Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.
- Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease
- Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.
- T CELL DEPLETION WITH CAMPATH‐1 IN ALLOGENEIC BONE MARROW TRANSPLANTATION
- Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody.
- Epstein-Barr virus infection and immunity in bone marrow transplant recipients.
- CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S
- Advances in the diagnosis and treatment of EBV‐associated lymphoproliferative diseases in immunocompromised hosts
- The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.
- Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated
- Long internal direct repeat in Epstein-Barr virus DNA
Cited by
- Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
- CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
- Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice.
- Activated Long-Term Peripheral Blood Cultures as Preparation for Adoptive Alloreactive Cell Therapy in Cancer Patients
- Adoptive immunotherapy following allogeneic bone marrow transplantation.
- AIDS-related malignancies.
- The Epstein-Barr virus and its association with human cancers.
- Successful hematopoietic stem cell transplantation for aplastic anemia following living-related liver transplantation
- A novel ‘sort-suicide’ fusion gene vector for T cell manipulation
- ‘GVHD’: graft-versus-host disease or graft-versus-Hodgkin's disease? an old acronym with new meaning
- Nonmyeloablative allogeneic immunotherapy for solid tumors.
- The ABCs of artificial antigen presentation
- Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.
- Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.
- Applications of gene transfer in hematologic malignancy.
- Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment.
- Infusion of leukocytes from HLA haplo-identical familial donors as an adjuvant in the HLH-2004 protocol to treat the virus-associated adult hemophagocytic lymphohistiocytosis: a retrospective study of 26 patients
- Donor lymphocyte infusion for BK virus hemorrhagic cystitis and nephropathy: a case report
- Malignancies after hematopoietic stem cell transplantation: many questions, some answers.
- Cellular adoptive immunotherapy after bone marrow transplantation.
Related papers
- Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.
- [Diagnosis of lymphoproliferative diseases by bone marrow trepanobiopsy specimens].
- Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
- Epstein-Barr virus-related lymphoproliferative disorders
- B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization.
- Epstein Bar Virus—The Cause of Hodgkin’s Lymphoma
- EXPRESSION OF EPSTEIN BARR VIRUS (EBV) GENES IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLPDs).
- Epstein–Barr virus (EBV) load and interleukin‐10 in EBV‐positive and EBV‐negative post‐transplant lymphoproliferative disorders